Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-01-22 @ 2:45 PM
Study NCT ID:
NCT00403403
Status:
COMPLETED
Last Update Posted:
2011-04-29
First Post:
2006-11-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
Sponsor:
Genentech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AVF3995g
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
David Karlin, M.D., Study Director
Old Organization:
Genentech, Inc.